Inactive Instrument

Omthera Pharmaceuticals Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE
2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE

Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	13-06-10	RE
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	13-06-10	RE
GlaxoSmithKline plc : GSK bets on chimp virus with $321 million vaccines buy	13-05-29	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	13-05-28	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	13-05-28	RE

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	13-09-20	PU
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	13-07-16	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	13-07-09	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	13-06-27	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13-06-13	PR

Banques et statistiques ont soutenu Wall Street	13-05-28
Les valeurs à suivre aujourd'hui à Wall Street	13-05-28
Omthera Pharmaceuticals Inc : OMTHERA racheté par AstraZeneca	13-05-28

Sector

	1st Jan change	Capi.
MERCK KGAA	+16.00%	78.51B
KYOWA KIRIN CO. LTD.	+13.10%	9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+58.17%	4.96B
SK BIOPHARMACEUTICALS CO., LTD.	-14.94%	4.84B
YUHAN CORPORATION	-.--%	3.72B
INDIVIOR PLC	+20.00%	2.48B
BETTA PHARMACEUTICALS CO., LTD.	-26.63%	2.19B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+16.75%	2.12B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-37.97%	1.94B